Skip to main content

Table 3 Mean differences in VAS score, MVJ score, and recurrence rate after surgery

From: Laparoscopic adenomyomectomy combined with levonorgestrel-releasing intrauterine system is effective for long-term management of adenomyosis

 

Group A

Group B

Pa

Pb

Pc

3rd month

n = 69

n = 69

   

 VAS

0.21 (0.05–0.38)

0.81 (0.52–1.10)

<.001

<.001

<.001

 MVJ

1.03 (0.82–1.24)

2.41 (2.19–2.63)

<.001

<.001

<.001

 Recurrence, n(%)

0

0

-

  

6th month

n = 69

n = 68

   

 VAS

0.20 (0.04–0.37)

1.04 (0.69–1.40)

<.001

<.001

<.001

 MVJ

1.03 (0.82–1.24)

2.74 (2.47-3.00)

<.001

<.001

<.001

 Recurrence, n%

0

3 (4.41%)

.039

  

12th month

n = 69

n = 68

   

 VAS

0.26 (0.05–0.47)

1.39 (0.98–1.79)

<.001

<.001

<.001

 MVJ

0.97 (0.77–1.17)

2.70 (2.44–2.96)

<.001

<.001

<.001

 Recurrence, n(%)

1 (1.45%)

9 (13.24%)

.009

  

24th month

n = 69

n = 67

   

 VAS

0.35 (0.09–0.60)

1.52 (1.04–2.01)

<.001

<.001

<.001

 MVJ

1.04 (0.81–1.27)

2.74 (2.47–3.01)

<.001

<.001

<.001

 Recurrence, n(%)

1 (1.45%)

14 (20.90%)

<.001

  

36th month

n = 68

n = 67

   

 VAS

0.47 (0.10–0.84)

1.84 (1.25–2.42)

<.001

<.001

<.001

 MVJ

1.09 (0.84–1.34)

2.95 (2.66–3.24)

<.001

<.001

<.001

 Recurrence, n(%)

2 (2.94%)

22 (32.84%)

<.001

  
  1. Abbreviation: MVJ Mansfield-Voda-Jorgensen Menstrual Bleeding Scale, VAS Visual analog scale
  2. a Group A compared with group B
  3. b Compared with preoperative in group A
  4. c Compared with preoperative in group B